Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

Celltrion
Biotech
Moderna
AbbVie
Gilead Sciences
Topics

Advertisement

Advertisement

Celltrion

Share

Top Latest Popular

In the last 4 hours

Celltrion and Kaigene sign $580m licence deal for KG013 Hospital Management 10:44

Yesterday

Kaigene Enters into Exclusive Global Licensing Agreement with Celltrion for Next-Generation Anti-April Antibody KG013 PR Newswire (Press Release) 14:02 Thu, 22 Oct

Celltrion secures three autoimmune drug candidates through deal with U.S. firm Kaigene Asia Today 07:20 Thu, 22 Oct

Advertisement

Advertisement

Celltrion deepens bet on US biotech Kaigene with 3rd autoimmune drug candidate Korea Biomedical Review 05:38 Thu, 22 Oct

In the last month

Celltrion to highlight Remsima SC clinical data at UEG Week 2026 The Korea Herald 03:28 Thu, 15 Oct

Celltrion to present real-world Remsima SC data at UEG Week 2026 Korea Biomedical Review 02:35 Thu, 15 Oct

Celltrion to Spotlight Subcutaneous (SC) Infliximab (Remsima™ SC) and Broader IBD Portfolio at Ueg Week 2026 Business Wire (Press Release) 01:16 Thu, 15 Oct

Celltrion Launches Omalizumab Biosimilar in the United States JD Supra 23:54 Wed, 14 Oct

Celltrion nears additional contract with major U.S. PBM Asia Today 05:20 Wed, 14 Oct

Spotlight On: Herceptin® (trastuzumab) / Ogivri® (trastuzumab-dkst) / Herzuma® (trastuzumab-pkrb) / Ontruzant® (trastuzumab-dttb)... JD Supra 17:33 Tue, 13 Oct

Celltrion's operating profit jumps 69% as revenue rises 46%, but ensuring profitability remains key Asia Today 01:42 Tue, 13 Oct

Spotlight On: Biosimilar Litigations - October 2026 JD Supra 22:31 Mon, 12 Oct

Celltrion Q3 operating profit tops W500 bil. mark for 1st time The Korea Times 07:18 Mon, 12 Oct

Celltrion posts first W500b quarterly operating profit The Korea Herald 03:29 Mon, 12 Oct

Advertisement

Celltrion's profit outpaces sales growth as newer biosimilars gain ground Korea Biomedical Review 01:35 Mon, 12 Oct

Celltrion to Present New Analyses of Zymfentra® (infliximab-dyyb) in Crohn's Disease and Ulcerative Colitis at ACG 2026 PR Newswire (Press Release) 18:02 Sun, 11 Oct

Celltrion expands Avtozma's US label to Covid-19 patients aged 2 and older Korea Biomedical Review 08:37 Wed, 07 Oct

Celltrion prices Omlyclo 15% below Xolair in US launch Korea Biomedical Review 02:31 Tue, 06 Oct

Celltrion Launches Omlyclo, First Interchangeable Omalizumab Biosimilar In U.S. RTT News 17:03 Mon, 05 Oct

Omlyclo® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to Xolair®, now commercially available in the U.S. PR Newswire (Press Release) 13:51 Mon, 05 Oct

Celltrion expands European reach with tender wins for 3 new products Korea Biomedical Review 02:11 Thu, 01 Oct

Celltrion seeks new partners, clients at CPHI The Korea Herald 06:31 Tue, 29 Sep

Celltrion targets CDMO deals, supply-chain partners at CPHI 2026 Korea Biomedical Review 06:20 Tue, 29 Sep

Celltrion to seek new drug, CDMO partners at int'l pharmaceutical exhibition in Milan The Korea Times 05:04 Tue, 29 Sep

Celltrion seeks rheumatoid arthritis indication expansion for Zymfentra Asia Today 07:45 Wed, 23 Sep

Advertisement

Advertisement

About our Celltrion news

Latest news on Celltrion, a biopharmaceutical company headquartered in Incheon, South Korea.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Business Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna